CTC vs Hepatox

CTC-AE is a reference and educational tool for clinical researchers, oncologists, and healthcare professionals working with adverse event terminology and oncology performance status scales. The app provides fast, offline access to publicly available standards: • NCI Common Terminology Criteria for Adverse Events (CTC-AE v4.03 and v5.0) • ECOG Performance Status • Karnofsky Performance Status • Lansky Performance Status (pediatric) You can also keep personal reference notes about trials and patients, stored privately in your own iCloud account and synced across your Apple devices. Export your data as CSV at any time. KEY FEATURES • Complete CTC-AE v4.03 and v5.0 terminology with grades and definitions • Color-coded severity grades for quick visual reference • Multi-column layout optimized for iPad • Performance status scales (ECOG, Karnofsky, Lansky) • Personal trial and patient reference notes, stored privately in your own iCloud account and synced across iPhone, iPad, and Mac • CSV export • Optional Face ID / Touch ID protection • Optional name scrambling for on-screen privacy PRIVACY Your reference notes live in your private iCloud container. Arpacore B.V. has no access to this data, and no information is shared with any third party. INTENDED USE CTC-AE is intended for educational and reference purposes only. It is not a medical device. It is not intended to diagnose, prevent, monitor, predict, prognose, or treat any disease, injury, or disability, and does not provide medical advice. All clinical decisions remain the sole responsibility of qualified healthcare professionals. The CTC-AE terminology is published by the U.S. National Cancer Institute and is reproduced here for reference. This app is not affiliated with, endorsed by, or sponsored by the NCI or NIH. CTC-AE is also available natively on Mac, with full sync between your devices.

Hepatox®, a bibliographical database which reviews drug-induced liver injury, was created in 1980 by Michel BIOUR (MD, PhD), and has been monthly updated in accordance with other usual bibliographical databases to the analysis of the references cited in the articles. All the published cases for selection and classification were re-evaluated in accordance with criterions usually validated in hepatology. 1600 drugs are registered with 20,000 corresponding references. We provide the number of references for each type of liver disorder and one selected reference for each drug.